benzoylarginine-2-naphthylamide has been researched along with kallidin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cezari, MH; Juliano, L; Juliano, MA; Portaro, FC; Prado, ES; Walmsley, AR | 1 |
1 other study(ies) available for benzoylarginine-2-naphthylamide and kallidin
| Article | Year |
|---|---|
Design of kallidin-releasing tissue kallikrein inhibitors based on the specificities of the enzyme's binding subsites.
Topics: Benzoylarginine-2-Naphthylamide; Humans; Kallidin; Kallikreins; Kinetics; Peptides; Tissue Kallikreins; Vasoconstrictor Agents | 1997 |